ENDOTIS

Endotis discovers, develops, and manufactures cardiovascular therapeutics. The company also discovers and develops small-glyco drugs for applications in thrombosis, oncology, and hematology areas. Its portfolio of products includes EP217609, a neutralizable anti-coagulant for managing extracorporeal blood circulation during open-heart surgery; FondaParinux, an injectable drug for the prevention and treatment of venous thromboembolism; and an oral anti-coagulant for stroke prevention in atrial fibrillation. Endotis was founded in 2003 and is based in Romainville, France.

#SimilarOrganizations #People #Financial #Website #More

ENDOTIS

Social Links:

Facebook

Linkedin

Industry:

Biopharma Biotechnology Health Care Manufacturing Therapeutics

Founded:

2003-01-01

Address:

Romainville, Ile-de-France, France

Country:

France

Website Url:

http://www.endotis.com

Total Employee:

1+

Status:

Active

Contact:

33 1 48 46 43 91

Total Funding:

29 M EUR

Technology used in webpage:

SPF Amazon Amazon Ohio Region NameBright

Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

novolytics-logo

Novolytics

Novolytics is developer of bacteriophage-based therapeutics.

Current Advisors List

rafaele-tordjman_image

Rafaele Tordjman Member of the Board of Directors @ Endotis
Board_member

Investors List

wellcome-trust_image

Wellcome Trust

Wellcome Trust investment in Series B - Endotis

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Series A - Endotis

Official Site Inspections

http://www.endotis.com

Host Informations
Whois Informations

Loading ...

More informations about "Endotis" on Search Engine